JPRN-UMIN000021801已完成2 期
Study on efficacy and safety of Hochuekkito for the treatment of partial paralysis as a complication of cerebrovascular disorder - Efficacy of Hochuekkito for "partial paralysis" in patients undergoing rehabilitation
Department of Rehabilitation Tsuruoka Kyoritu Rehabilitation Hospital0 个研究点目标入组 100 人开始时间: 2016年4月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have any of the following conditions: 1)Insufficient nutrition intake (less than 1,400kcal/day) 2)CRP of 10g/dL or more 3)Grade 2 or severer on the physical disability certificate or Grade 3 or severer certification of long-term care need since before the onset of cerebrovascular disorder 4)Use of any Kampo medicine within 4 weeks before study initiation 5)Serious comorbidities (e.g., hepatic, renal, cardiac, hematological, and metabolic diseases) 6)Any other condition assessed as inappropriate for study participation by the investigator or subinvestigator (hereinafter referred to as "investigators, etc.")
研究者
相似试验
已完成
不适用
A study on the efficacy and safety of Hochuekkito for anorexia of elderly gastric cancer patientsElderly gastric cancer patients who are scheduled for gastrectomyJPRN-UMIN000018451Department of Surgery, Iwate Medical University, School of Medicine60
尚未招募
2 期
Evaluate the effect of Ghritkumaryadi Aschyotan (Eye drops) with Glycerine in the Management of Computer Vision SyndromeCTRI/2024/07/070899Principal Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital Paprola
招募中
不适用
medicated planned emesis treatment in hypothyroidismCTRI/2018/02/011993Govt akhandanand ayurved college
招募中
2 期
A study to find out the effectiveness of oral temozolomide along with radiation in patients with grade IV glial tumors using a short course of Intensity modulated RadiotherapyCTRI/2021/01/030334Christian Medical College Vellore
尚未招募
不适用
Pilot study of efficacy and safety of Rikkunshito for adverse events (nausea, emesis and anorexia) caused by chemotherapy (modified MAID therapy) for high grade bone and soft tissue sarcomas.High-grade bone and soft tissue sarcomasJPRN-UMIN000015113Tokyo Metropolitan Komagome Hospital10